{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:04:59Z","timestamp":1791003899391,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.diagmicrobio.2013.04.004","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T03:57:31Z","timestamp":1369799851000},"page":"335-338","source":"Crossref","is-referenced-by-count":47,"title":["In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48\u2013positive Klebsiella pneumoniae strains"],"prefix":"10.1016","volume":"76","author":[{"given":"Ebru","family":"Evren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem Kurt","family":"Azap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eule","family":"\u00c7olako\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0005","first-page":"311","article-title":"Fosfomycin: past, present and future","volume":"44","author":"Baylan","year":"2010","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/cid\/cir401","article-title":"Colistin-resistant, Klebsiella pneumonia carbapenemase (KPC)\u2013producing Klebsiella pneumoniae belonging to the International Epidemic Clone St258 Clinical Infectious Diseases","volume":"53","author":"Bogdanovich","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe","volume":"18","author":"Canton","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1469-0691.2009.03115.x","article-title":"Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control","volume":"16","author":"Carmeli","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0025","series-title":"Performance standards for antimicrobial susceptibility testing; 18th informational supplement (M100-S21)","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2011"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0030","series-title":"Performance standards for antimicrobial susceptibility testing; 22nd informational supplement (M100\u2013S22)","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1469-0691.2009.03114.x","article-title":"The emerging threat of acquired carbapenemases in Gram-negative bacteria","volume":"16","author":"Cornaglia","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0170","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.50.1.368-370.2006","article-title":"In vitro activity of fosfomycin against extended-spectrum-\u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures","volume":"50","author":"Cueto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of \u03b2-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7883\/yoken.JJID.2009.372","article-title":"The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp","volume":"62","author":"Durmaz","year":"2009","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum \u03b2-lactamase producing Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0055","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkq108","article-title":"Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection","volume":"65","author":"Hirsch","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00228-010-0794-5","article-title":"Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria","volume":"66","author":"Kastoris","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2004.10.001","article-title":"Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria","volume":"25","author":"Li","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","article-title":"What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0075","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/AAC.01020-10","article-title":"Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan","volume":"55","author":"Marchaim","year":"2011","journal-title":"Antimicrobial Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0080","first-page":"209","article-title":"Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm","volume":"59","author":"Mikuniya","year":"2005","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0085","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jac\/dkr563","article-title":"Rapid detection of carbapenemase genes by multiplex real-time PCR","volume":"67","author":"Monteiro","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0090","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1111\/1469-0691.12091","article-title":"Bacteramia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge","volume":"19","author":"Navarro-San Francisco","year":"2013","journal-title":"Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0095","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","article-title":"The real threat of Klebsiella pneumoniae carbapenemase producing bacteria","volume":"9","author":"Nordmann","year":"2009","journal-title":"Lancet Infect Dis rev"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s101560200004","article-title":"Effectiveness of fosfomycin combined with other antimicrobial agents against multidrug-resistant Pseudomonas aeruginosa isolates using the efficacy time index assay","volume":"8","author":"Okazaki","year":"2002","journal-title":"J Infect Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0110","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/AAC.00296-11","article-title":"Carbapenems: past, present, and future","volume":"55","author":"Papp-Wallace","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.48.1.15-22.2004","article-title":"Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumonia","volume":"48","author":"Poirel","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0120","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/jac\/dks121","article-title":"OXA-48-like carbapenemases: the phantom menace","volume":"67","author":"Poirel","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0125","first-page":"1239","article-title":"In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa","volume":"36","author":"Pruekprasert","year":"2005","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1469-0691.2011.03636.x","article-title":"Fosfomycin: an old\u2013new antibiotic","volume":"18","author":"Raz","year":"2012","journal-title":"Clin Microbiol Infect Rev"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0135","first-page":"61","article-title":"Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient","volume":"18","author":"Rodr\u00edguez-Avial","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0140","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijantimicag.2009.08.013","article-title":"Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections","volume":"34","author":"Roussos","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0145","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10096-011-1360-5","article-title":"E. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa clinical isolates","volume":"31","author":"Samonis","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0150","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1128\/AAC.00234-12","article-title":"In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli","volume":"56","author":"Spanu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.04.004_bb0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijantimicag.2010.05.014","article-title":"Guideline for pheonotypic screening and confirmation of carbapenemases in Enterobacteriaceae","volume":"36","author":"Stuart","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0160","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijantimicag.2005.10.012","article-title":"In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units","volume":"27","author":"Timurkaynak","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2013.04.004_bb0165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000100811","article-title":"Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa","volume":"53","author":"Yamada","year":"2007","journal-title":"Chemotherapy"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889313002083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889313002083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T23:53:51Z","timestamp":1688255631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889313002083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0732889313002083"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.04.004","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}